首页|Risk and Management of Intracerebral Hemorrhage in Patients with Bleeding Disorders

Risk and Management of Intracerebral Hemorrhage in Patients with Bleeding Disorders

扫码查看
Intracerebral hemorrhage (ICH) is the most dreaded complication, and the main cause of death, in patients with congenital bleeding disorders. ICH can occur in all congenital bleeding disorders, ranging from mild, like some platelet function disorders, to severe disorders such as hemophilia A, which can cause catastrophic hemorrhage. While extremely rare in mild bleeding disorders, ICH is common in severe coagulation factor (F) XIII deficiency. ICH can be spontaneous or trauma-related. Spontaneous ICH occurs more often in adults, while trauma-related ICH is more prevalent in children. Risk factors that can affect the occurrence of ICH include the type of bleeding disorder and its severity, genotype and genetic polymorphisms, type of delivery, and sports and other activities. Patients with hemophilia A; afibrinogenemia; FXIII, FX, and FVII deficiencies; and type 3 von Willebrand disease are more susceptible than those with mild platelet function disorders, FV, FXI, combined FV–FVIII deficiencies, and type 1 von Willebrand disease. Generally, the more severe the disorder, the more likely the occurrence of ICH. Contact sports and activities can provoke ICH, while safe and noncontact sports present more benefit than danger. An important risk factor is stressful delivery, whether it is prolonged or by vacuum extraction. These should be avoided in patients with congenital bleeding disorders. Familiarity with all risk factors of ICH can help prevent occurrence of this diathesis and reduce related morbidity and mortality.

intracerebral hemorrhagecongenital bleeding disordersmorbiditymortality

Kamand Haeri、Omid Baradarian Ghanbari、Abbas Ahmadi、Akbar Dorgalaleh、Yadolah Farshi

展开 >

Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine

Department of Hematology and Blood Transfusion, School of Allied Medicine, Iran University of

Cellular and Molecular Research Center, Research Institute for Health Development, Kurdistan

Department of Hematology and Blood Transfusion, Tehran University of Medical Sciences

展开 >

2022

Seminars in Thrombosis and Hemostasis

Seminars in Thrombosis and Hemostasis

SCI
ISSN:0094-6176
年,卷(期):2022.48(3)
  • 5
  • 121